Skip to main content
Mabion S.A. logo

Mabion S.A. — Investor Relations & Filings

Ticker · MAB ISIN · PLMBION00016 LEI · 259400KG5JVQPPZL6X53 WAR Manufacturing
Open in API
Filings indexed 1,002 across all filing types
Latest filing 2021-09-16 Audit Report / Informat…
Country PL Poland
Listing WAR MAB

About Mabion S.A.

https://www.mabion.eu/en/

Mabion S.A. is an integrated Contract Development and Manufacturing Organization (CDMO) that provides end-to-end services for the development and manufacturing of protein-based biotherapeutics. The company specializes in monoclonal antibodies and biosimilars, offering a complete workflow from cell line development and banking to process optimization and large-scale GMP manufacturing. Core competencies include upstream processing using mammalian cell cultures, downstream purification involving chromatography and viral clearance, and technology transfer for scale-up. Mabion partners with pharmaceutical and biotechnology companies to support both clinical and commercial supply, streamlining the path from gene to final drug product.

Recent filings

Filing Released Lang Actions
Raport Biegłego Rewidenta
Audit Report / Information Classification · 98% confidence The document is titled "Raport niezależnego biegłego rewidenta z przeglądu śródrocznego skróconego sprawozdania finansowego" (Independent Auditor's Report on the Review of Condensed Interim Financial Statements). It explicitly discusses a 'przegląd' (review) of the 'śródrocznego skróconego sprawozdania finansowego' (condensed interim financial statements) for the period ending June 30, 2021. This content directly aligns with the definition of an Audit Report / Information (AR), which covers standalone audit reports and results of internal/regulatory stress tests, distinguishing it from a full Annual Report (10-K) or a general Interim Report (IR) by focusing specifically on the auditor's review conclusion. H1 2021
2021-09-16 Polish
Oświadczenie Zarządu w sprawie rzetelności sporządzenia sprawozdania finansowego
Regulatory Filings Classification · 95% confidence The document is a formal 'Statement of the Management Board' regarding the reliability of financial statements. It serves as an officer certification/attestation for the financial reports of Mabion S.A. for the period ending June 30, 2021. According to the 'Certification Rule', documents that are primarily officer certifications or attestations, even if they reference a specific report, should be classified as Regulatory Filings (RNS) rather than the report itself, as they do not contain the actual financial statements or substantive financial data. H1 2021
2021-09-16 Polish
Mabion_Sprawozdanie Zarządu
Management Reports Classification · 99% confidence The document title is "Sprawozdanie Zarządu z działalności Mabion S.A. w I półroczu 2021 roku" which translates to "Management Board Report on the activities of Mabion S.A. in the first half of 2021". The content includes a detailed Table of Contents covering financial data, management structure, business activities, risk analysis, and a comparative financial summary for the first half of 2021 (01.01.2021 do 30.06.2021). This structure and content strongly indicate a comprehensive financial report covering a period shorter than a full year (six months). This aligns perfectly with the definition of an Interim / Quarterly Report (IR). It is not a full Annual Report (10-K) because it explicitly covers the first half (I półroczu). It is a full report, not just an announcement of a report (RPA/RNS).
2021-09-16 Polish
Mabion MSSF_1H2021
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Śródroczne Skrócone Sprawozdanie Finansowe' (Interim Condensed Financial Statement) for Mabion S.A. for the 6-month period ending June 30, 2021. It contains detailed financial statements, including the Statement of Comprehensive Income, Statement of Financial Position, and Statement of Cash Flows. Since it is a comprehensive financial report for a period shorter than a full fiscal year and contains actual financial data, it is classified as an Interim/Quarterly Report. H1 2021
2021-09-16 Polish
Statut - tekst jednolity
Regulatory Filings Classification · 99% confidence The document text is titled "STATUT SPÓŁKI" (Company Statute) and contains detailed articles (§) covering general provisions, the company's business activities (PKD codes), founders, capital structure (including detailed breakdown of share series, voting rights, and nominal value), conditional capital increases related to warrants, and rules for share transfer, pre-emption rights, and right of first refusal. This content is characteristic of a company's foundational legal document, which is typically filed with regulatory bodies or maintained as a core corporate governance document. Among the provided codes, 'Governance Information' (CGR) is the closest fit for a document detailing the internal rules, structure, and statutes of a company, although it is not a standard SEC filing type. Given the highly specific nature of the definitions, and that this is the foundational legal document outlining structure and governance, CGR is the most appropriate classification, as it is not an Annual Report (10-K), an Earnings Release (ER), or a proxy statement (DEF 14A/PSI).
2021-08-10 Polish
Rejestracja zmian Statutu Spółki - Content (PL)
AGM Information Classification · 99% confidence The document is a current report ("raport bieżący") from Mabion S.A. informing that the District Court registered changes to the Company's Articles of Association ("Statutu Spółki"), which were approved by the Ordinary General Meeting ("Zwyczajne Walne Zgromadzenie") on June 22, 2021. The text includes the full, consolidated version of the amended Articles of Association, detailing changes to the company's scope of business (PKD codes) and governance rules (Board of Supervisors representation and voting). This type of filing, which announces a formal change to the company's foundational documents (Statute) following a shareholder vote, is a significant corporate event announcement. Since it is not a standard financial report (10-K, IR, ER) or a proxy statement (DEF 14A/PSI), and it relates to fundamental corporate structure changes approved by shareholders, it fits best under general Regulatory Filings (RNS) or potentially a specific corporate action category. Given the options, and that it is a formal announcement of a statutory change registered by a court, RNS (Regulatory Filings) is the most appropriate general category for non-standard, mandatory corporate disclosures in this context, although it is a very specific type of corporate governance update. However, since the core content is the registration of changes to the Statute, which is a fundamental corporate governance document, and it is not explicitly covered by MANG, CGR, or SHA, RNS serves as the best fit for this type of official regulatory update.
2021-08-10 Polish

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.